Great Lakes Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-124,340
Closed -$6.48M 809
2025
Q2
$6.48M Sell
124,340
-11,702
-9% -$642K 0.05% 245
2025
Q1
$8.22M Buy
136,042
+30,643
+29% +$1.98M 0.07% 214
2024
Q4
$7.21M Sell
105,399
-7,034
-6% -$490K 0.06% 248
2024
Q3
$8.09M Sell
112,433
-17,223
-13% -$1.22M 0.07% 236
2024
Q2
$8.99M Sell
129,656
-693
-0.5% -$50.6K 0.08% 212
2024
Q1
$10.4M Sell
130,349
-4,443
-3% -$396K 0.09% 207
2023
Q4
$14.8M Buy
134,792
+3,386
+3% +$350K 0.14% 156
2023
Q3
$13.3M Sell
131,406
-59,762
-31% -$6.87M 0.12% 162
2023
Q2
$26M Buy
191,168
+4,554
+2% +$556K 0.26% 104
2023
Q1
$19.4M Buy
+186,614
New +$18M 0.18% 127
2022
Q3
Sell
-76,804
Closed -$7.36M 658
2022
Q2
$7.36M Sell
76,804
-3,184
-4% -$382K 0.15% 177
2022
Q1
$11.9M Buy
+79,988
New +$11.2M 0.19% 141

Other funds holding CNMD

Great Lakes Advisors's CNMD Position: Q3 2025 in Review

Great Lakes Advisors sold out of CONMED (CNMD) in Q3 2025, closing a stake of 124,340 shares — an estimated $6.48M sold.

Great Lakes Advisors first reported a position in CNMD in Q1 2022 and held it in 12 quarters. The position peaked at $26M in Q2 2023. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Great Lakes Advisors reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Great Lakes Advisors sold 124,340 CONMED shares in Q3 2025, an estimated $6.48M.
  • Great Lakes Advisors first reported a position in CONMED in Q1 2022 and held it in 12 quarters.
  • Great Lakes Advisors's CONMED position peaked at $26M in Q2 2023.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Great Lakes Advisors's 13F filing for Q3 2025, filed 3 Nov 2025.